2020 Outlook on the World Singlecell Technologies Field – Industry Sizing was Above $800 Million in 2019 – ResearchAndMarkets.com

DUBLIN–(Business enterprise WIRE)–The “Singlecell Know-how Marketplace Landscape 2020” report has been extra to ResearchAndMarkets.com’s featuring.

The global single cell technological innovation (SCT) industry has emerged since 2014. There are above 43 businesses with different 49 SCT goods commercialized throughout the world, and above 15 pre-commerce-phase startups are lined up and hold rising. The industry dimensions is in excess of $800 M in 2019, at a CAGR of ~24%.

The marketplace is anticipated to expand appreciably by the developing recognition of the solitary mobile tasks between biology communities, the expansion of precision drugs and diagnostic field, the antibody therapeutic drug progress, the entry of new players, etcetera.

Having said that, the superior price of the products, the necessity of in-person demo, various remaining specialized problems & defaults of the goods that rushed into the market place as well early, and lack of interdisciplinary experience on the shopper sides could limit the sector expansion premiums. Acquisitions and partnerships are actively viewed as for most of the aggressive know-how field.

The greater part (~60%) of the market gamers are small-sized startup providers with below 100 staff members, nevertheless, the sector share is highly concentrated on 4 significant firms (BD, 10x genomics, Fluidigm, and Berkeley gentle), still this market share can adjust as the industry is growing and far more new players are moving into, additional differentiation amid gamers is predicted.

Primarily, the SCT marketplace has a intricate sector framework characterized by its large array of know-how mixtures and several forms of end users throughout various daily life science exploration fields. The normal functionalities of the SCT are: one cell (SC) isolation, SC-sequencing, SC-protein analysis, or SC-focused manipulation. Between all those, the first two classification products and solutions (SC-isolation and SC-sequencing) account for ~72% of the sector.

SCT can be applied in most of the daily life science application as it is described by any biological science experimentation that handles and deliver single cell resolution details. Stem cell investigation and cancer study are the fields of studies that have tailored SCT the most, and immunology and neurobiology also have a developing want in SCT. The market place is categorized by the main systems (11 types) and by the apps (5 types).

The main technology types involve common cell choosing, constrained dilution, FACS, and laser capture microdissection (LCM) technologies, but also novel systems for computerized one mobile choosing, automatic solitary cell dispensing, microwell-based solitary mobile isolation/examination, microfluidic chip based mostly-solitary mobile investigation, droplet microfluidics-dependent, novel cytometry, and mobile manipulation. The 5 sector application types contain SC-isolation, SC-DNA/RNA sequencing, cell line development, protein or functional assessment, and drug discovery & diagnostics.

Businesses Talked about

  • 10x genomics
  • Becton Dickinson (BD)
  • Berkeley lights
  • Bio-rad
  • Carl Zeiss
  • Celsee
  • Dolomite bio
  • Eppendorf
  • Fluicell
  • Fluidigm
  • iBiochips
  • IsoPlexis
  • Leica Microsystems
  • Luminex
  • Menarini Silicon Biosystems
  • MissionBio
  • NanoCellect
  • Perkin Elmer
  • ProteinSimple
  • QIAgen
  • RareCyte
  • Sony biotechnology
  • TaKaRa Bio

Crucial Topics Lined:

Preface

Executive Summary

Section Just one: the Industry and Technique Perspectives

Chapter 1 Market place Framework and Sector Dimensions

1.1 Sector Construction

  • The Complexity of the SCT Current market
  • Sector Players

1.2 Marketplace Dimensions

  • Current market Size by Revenue
  • Current market Share
  • Sector Forecast

1.3 Market’s Dynamic Growth & Restraint Factors

  • External Influencers
  • The Time is Now: a Paradigm Change in Biology Investigate

Chapter 2 Projecting Strategic Ideas

2.1 Strategic Moves by Current SCT Organizations

  • R&D Expenses
  • Latest Partnerships and Acquisitions
  • Advertising Channels

2.2 Market place Innovating System

  • The Core Strategy of Method and a Principle of Trade-Off

Element Two: Biology and Its Evolution- Current market from the Buyers Point of view

Chapter 3 Single Cell Biology by -Omics and Area of Examine

3.1 Single Cell Biology: Physics and Engineering Fulfill Biology

  • Why One Cell
  • Remained Challenges in SC Scientific studies

3.2 One Cell Biology by -Omics Fields

  • What is Inside of a Cell?
  • Intro to Genomics, Epi-Genomics, and Transcriptomics (=Sequencing Omics)
  • Introduction to Proteomics
  • Other Omics That Comprehensive Phenomics, Built-in Omics

3.3 Solitary Mobile Biology by Field of Scientific studies

  • SCT Can be Applied in Practically Each individual Existence Science Domain
  • Well-known Fields of Research

Chapter 4 Being familiar with the Purchaser and Their Workflow

4.1 Understand the Customer’s Workflow

  • One-Cell Examination Workflow

4.2 Have an understanding of the Customer Practical experience Cycle

  • The Price vs the Worth Before Making a Purchase Selection

Aspect 3: Market from the Technological know-how Suppliers Standpoint

Chapter 5 Sector Segments by Engineering

5.1 Overview

5.2 Guide Buying

5.3 Constrained Dilution

5.4 FACS: Fluorescence Activated Mobile Sorter

  • Limitation of FACS
  • Marketplace Developments for Facs and Emergence of Microfluidic Chip-Based Mobile Sorter

5.5 Laser Seize Microdissection (LCM)

5.6 Automated Single Mobile Pickers

5.7 Solitary Mobile Dispensing

5.8 Microwell Centered Single Cell Isolation

5.9 Microfluidics Chip-Primarily based One Mobile Analysis

5.10 Droplet Microfluidics

5.11 New Style of Cytometry and Spectroscopy

5.12 Fluidics and Mobile Manipulation

Chapter 6 Sector Segments by Applications

6.1 Overview

6.2 SC-Dna and Rna Sequencing

6.3 Cell Line Advancement

6.4 Protein or Purposeful Analysis

6.5 Drug Discovery and Diagnostics

Chapter 7 Rising Early Phase SCT Startup Businesses

7.1 Emerging Early Phase SCT Startup Companies

or additional data about this report take a look at https://www.researchandmarkets.com/r/6q7yf9